The controversy stems from the US administration's proposal to link US drug prices to lower prices paid in other developed countries. Drugmakers fear that if they launch new drugs at lower prices in Europe (perhaps to comply with local regulations or market pressures), these lower prices could then be used as a benchmark to force down prices in the much larger and more lucrative US market. To avoid setting a global low-price precedent, companies are strategically delaying new medicine launches in Europe.

MFN exists to solve the problem of 'trade discrimination' and 'protectionism'. Historically, countries would grant preferential treatment (like lower tariffs) to a select few trading partners, often based on political alliances or bilateral deals, while imposing higher barriers on others. This created an uneven playing field, distorted trade flows, and hindered overall global economic growth. MFN mandates that any trade concession granted to one country must be extended to all other trading partners, promoting fairness and predictability.

The MFN principle ensures a 'level playing field' by prohibiting discriminatory trade practices. When a country applies the same tariff rates and trade conditions to all its MFN partners for 'like products', it prevents any single country from gaining an unfair advantage through preferential treatment. This means businesses from different countries face similar barriers when exporting to a particular market, fostering fair competition based on product quality and price rather than on political favouritism.

The primary legal basis for the MFN principle is Article I of the General Agreement on Tariffs and Trade (GATT) 1994. This article, often referred to as the 'General Most-Favoured-Nation Treatment' clause, is a foundational element of the World Trade Organization (WTO) Agreement and is binding on all WTO member countries.

MFN treatment extends beyond just tariff rates. It also covers quantitative restrictions (like quotas), internal taxes and charges, laws and regulations affecting internal sale, purchase, transportation, distribution, or use of products, and other trade advantages. The key is that any privilege granted to one trading partner regarding these aspects must be extended to all other MFN partners for like products.

Critics argue that strict adherence to MFN can stifle a country's ability to pursue strategic trade policies or regional integration. For instance, it can prevent a country from offering deeper tariff cuts or special economic incentives to its immediate neighbours or within a regional bloc (like ASEAN or the EU) to foster closer economic ties and development. They contend that MFN's 'one-size-fits-all' approach doesn't always serve a nation's specific economic or geopolitical interests, especially for developing economies seeking tailored support.

India, as a WTO member, is bound by the MFN principle. This means India must extend any trade concession (like lower tariffs on specific goods) it grants to one WTO member to all other WTO members. This ensures that India's trading partners are treated equitably, promoting predictability and fairness in its trade dealings. While India also engages in bilateral and regional trade agreements (which have specific MFN exceptions), the MFN principle forms the bedrock of its non-discriminatory trade relations with the broader WTO membership.

Without MFN, global trade would likely become highly fragmented and unpredictable. Countries would be free to grant highly preferential treatment to a few 'favoured' nations and impose punitive tariffs on others. This would lead to: 1. Increased costs for consumers as goods from non-favoured countries become more expensive. 2. Reduced choice for consumers due to fewer import options. 3. Hindered competition, potentially leading to monopolies and less innovation. 4. Increased trade disputes and protectionism, making global supply chains fragile.

• •Increased consumer prices due to higher tariffs on goods from non-favoured nations.
• •Reduced variety and availability of imported goods.
• •Distorted competition, favouring politically connected suppliers.
• •Greater potential for trade wars and protectionist policies.

While MFN is a cornerstone of non-discrimination, its effectiveness in promoting *global economic equality* is debatable. Arguments for effectiveness: It prevents powerful nations from exploiting smaller economies through discriminatory tariffs, ensuring a baseline level of fairness. Arguments against effectiveness: 1. Exceptions: FTAs, Customs Unions, and special provisions for developing countries dilute the universal application of MFN. 2. Bilateral Power Imbalances: MFN doesn't prevent powerful nations from exerting influence through non-tariff barriers, subsidies, or other means not strictly covered by MFN. 3. Focus on Tariffs: It primarily addresses tariffs, while other forms of protectionism or market access issues persist. 4. Development Needs: Critics argue that developing countries sometimes need tailored preferential treatment (beyond what MFN allows) to build their industries, which universal MFN can hinder.

MFN is a principle of non-discrimination applied *among all* WTO members, while FTAs are agreements between a *subset* of countries to eliminate or reduce tariffs and other barriers *among themselves*, often going beyond MFN's scope but not necessarily extending those deeper preferences to non-members.

The controversy stems from the US administration's proposal to link US drug prices to lower prices paid in other developed countries. Drugmakers fear that if they launch new drugs at lower prices in Europe (perhaps to comply with local regulations or market pressures), these lower prices could then be used as a benchmark to force down prices in the much larger and more lucrative US market. To avoid setting a global low-price precedent, companies are strategically delaying new medicine launches in Europe.

MFN exists to solve the problem of 'trade discrimination' and 'protectionism'. Historically, countries would grant preferential treatment (like lower tariffs) to a select few trading partners, often based on political alliances or bilateral deals, while imposing higher barriers on others. This created an uneven playing field, distorted trade flows, and hindered overall global economic growth. MFN mandates that any trade concession granted to one country must be extended to all other trading partners, promoting fairness and predictability.

The MFN principle ensures a 'level playing field' by prohibiting discriminatory trade practices. When a country applies the same tariff rates and trade conditions to all its MFN partners for 'like products', it prevents any single country from gaining an unfair advantage through preferential treatment. This means businesses from different countries face similar barriers when exporting to a particular market, fostering fair competition based on product quality and price rather than on political favouritism.

The primary legal basis for the MFN principle is Article I of the General Agreement on Tariffs and Trade (GATT) 1994. This article, often referred to as the 'General Most-Favoured-Nation Treatment' clause, is a foundational element of the World Trade Organization (WTO) Agreement and is binding on all WTO member countries.

MFN treatment extends beyond just tariff rates. It also covers quantitative restrictions (like quotas), internal taxes and charges, laws and regulations affecting internal sale, purchase, transportation, distribution, or use of products, and other trade advantages. The key is that any privilege granted to one trading partner regarding these aspects must be extended to all other MFN partners for like products.

Critics argue that strict adherence to MFN can stifle a country's ability to pursue strategic trade policies or regional integration. For instance, it can prevent a country from offering deeper tariff cuts or special economic incentives to its immediate neighbours or within a regional bloc (like ASEAN or the EU) to foster closer economic ties and development. They contend that MFN's 'one-size-fits-all' approach doesn't always serve a nation's specific economic or geopolitical interests, especially for developing economies seeking tailored support.

India, as a WTO member, is bound by the MFN principle. This means India must extend any trade concession (like lower tariffs on specific goods) it grants to one WTO member to all other WTO members. This ensures that India's trading partners are treated equitably, promoting predictability and fairness in its trade dealings. While India also engages in bilateral and regional trade agreements (which have specific MFN exceptions), the MFN principle forms the bedrock of its non-discriminatory trade relations with the broader WTO membership.

Without MFN, global trade would likely become highly fragmented and unpredictable. Countries would be free to grant highly preferential treatment to a few 'favoured' nations and impose punitive tariffs on others. This would lead to: 1. Increased costs for consumers as goods from non-favoured countries become more expensive. 2. Reduced choice for consumers due to fewer import options. 3. Hindered competition, potentially leading to monopolies and less innovation. 4. Increased trade disputes and protectionism, making global supply chains fragile.

• •Increased consumer prices due to higher tariffs on goods from non-favoured nations.
• •Reduced variety and availability of imported goods.
• •Distorted competition, favouring politically connected suppliers.
• •Greater potential for trade wars and protectionist policies.

While MFN is a cornerstone of non-discrimination, its effectiveness in promoting *global economic equality* is debatable. Arguments for effectiveness: It prevents powerful nations from exploiting smaller economies through discriminatory tariffs, ensuring a baseline level of fairness. Arguments against effectiveness: 1. Exceptions: FTAs, Customs Unions, and special provisions for developing countries dilute the universal application of MFN. 2. Bilateral Power Imbalances: MFN doesn't prevent powerful nations from exerting influence through non-tariff barriers, subsidies, or other means not strictly covered by MFN. 3. Focus on Tariffs: It primarily addresses tariffs, while other forms of protectionism or market access issues persist. 4. Development Needs: Critics argue that developing countries sometimes need tailored preferential treatment (beyond what MFN allows) to build their industries, which universal MFN can hinder.

MFN is a principle of non-discrimination applied *among all* WTO members, while FTAs are agreements between a *subset* of countries to eliminate or reduce tariffs and other barriers *among themselves*, often going beyond MFN's scope but not necessarily extending those deeper preferences to non-members.